Our Leadership

Scott Schorer
Scott Schorer
PRESIDENT AND CEO

Companies

  • GI Dynamics
  • Systagenix
  • CentriMed / GHX
  • IST

Experience

  • Multiple clinical trials / regulatory approvals
  • Multiple exits
  • >$150m raised: public / private
  • Patents: 25 issued/pending

Education:

  • A.B: Dartmouth College
  • B.E.: Thayer School of Engineering, Dartmouth College
  • US Army Airborne Ranger
Serial entrepreneur - Deep fundraising/clin/reg/metabolic disease experience
Thomas Vasicek, PhD
Thomas Vasicek, PhD
CHIEF SCIENTIFIC OFFICER

Companies

  • Medtronic
  • Millennium
  • Corning
  • Lynx / Solexa
  • Roche

Experience

  • Multiple clinical trials
  • Patents: 10 issued/pending
  • Publications: 26+

Education:

  • B.S. Chemistry: MIT
  • PhD Genetics: Harvard University
  • Postdoc, Developmental Biology: Princeton University
Expert in targeted drug delivery, personalized medicine & metabolic hormones - Deep R&D/clin/reg experience
Sangeeta Kashyap, MD
Sangeeta Kashyap, MD
CHIEF MEDICAL OFFICER

Companies

• Janssen
• Ethicon
• Covidean
• Fractyl
• GI Dynamics

Experience

20+ clinical practice
• Multiple clinical trials funded by NIDDK, ADA and industry
• Publications: 120+

Education

• B.S. Biological Science, UC Irvine
• MD UC Irvine College of Medicine
• Postdoc, T32 and NRSA-NIDDK

Expert in obesity and metabolic disorder clinical trial and scientific discovery
Jon Freeman, MBA, CFM
Jon Freeman, MBA, CFM
CHIEF FINANCIAL OFFICER

Mr. Freeman has 25 years of finance, operations and management experience across a variety of industries including medical device, technology, industrial manufacturing, and professional services. He has worked in a wide range of environments, ranging from large public multi-national corporations down to small emerging private companies. Jon has helped lead several companies that have realized substantial shareholder value. Mr. Freeman holds a BA in Economics from St. Olaf College and an MBA from the University of Texas at Austin.

Our Scientific Advisors

Our Board of Directors

Scott Schorer
Scott Schorer
PRESIDENT AND CEO

Companies

  • GI Dynamics
  • Systagenix
  • CentriMed / GHX
  • IST

Experience

  • Multiple clinical trials / regulatory approvals
  • Multiple exits
  • >$150m raised: public / private
  • Patents: 25 issued/pending

Education:

  • A.B: Dartmouth College
  • B.E.: Thayer School of Engineering, Dartmouth College
  • US Army Airborne Ranger
Serial entrepreneur - Deep fundraising/clin/reg/metabolic disease experience
Richard G. Horan
Richard G. Horan
MANAGING PARTNER, BIOGRAPH VENTURES. GILA DIRECTOR

Biograph Venture

Biograph is an independent venture development firm established in 2018, focused in life sciences and healthcare

Previous positions:

  • Slater Technology Fund, Providence, RI
  • Sachem Ventures, Princeton, NJ
  • Johnston Associates, Princeton, NJ

CEO Positions

  • Medical Media Systems
  • SEQ/Praelux
  • Immunicon Corp

Education:

  • A.B.: Dartmouth College
  • MBA: Tuck School at Dartmouth
Christopher De Souza, PhD
Christopher De Souza, PhD
DIRECTOR, BROADVIEW VENTURES . GILA DIRECTOR

Broadview Ventures

Broadview is a philanthropic, for-profit venture fund supported by the Leducq Family Trust with a mission to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investments in and support of early-stage ventures

Current Director positions:

  • MassBio
  • Acesion, Mellitus, Giner Life Science

Education:

  • B.S., M.S.: University Mumbai
  • M.S., PhD: LSU
  • MBA: Rutgers University
Tim Barberich
Tim Barberich
GILA DIRECTOR

Experience

40+ years in medical device and pharmaceutical companies

Companies

  • Sepracor
  • Verastem (NASDAQ: VSTM)
  • Frequency Therapeutics (NASDAQ: FREQ)
  • TScan Therapeutics (NASDAQ: TCRX)

Founder and CEO

  • Sepracor: Founder & CEO (NASDAQ: SEPR) Sold to Dainippon for $2.6Bn

Education:

  • B.S. in Chemistry from Kings College